GSK's Augmentin Leads Indian Pharma Market in October with Rs 843 Crore Sales: Pharmatrac Report Farhat Nasim22 Nov 2024 5:40 PM ISTNew Delhi: As the Indian Pharmaceutical Market (IPM) continues its upward trajectory, Augmentin by GlaxoSmithKline (GSK) has stood the test of time...
NPPA Revises Ceiling Prices for 6 Drugs Including Clarithromycin, Vitamin C, Details Farhat Nasim20 Nov 2024 4:08 PM ISTNew Delhi: The National Pharmaceutical Pricing Authority (NPPA) has announced revised ceiling prices for six drug formulations following review orders...
Abbott Gets CDSCO Panel Nod To Manufacture, Market Clarithromycin ER Tablets 1000 mg Dr. Divya Colin7 Nov 2024 6:15 PM ISTNew Delhi: Pharmaceutical major Abbott has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Abbott initiates new clinical trial to improve outcomes in patients with advanced Heart Failure Ruchika Sharma31 Oct 2024 2:00 PM ISTAbbott Park, Ill.: Abbott has announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart...
No violation of Abbott's trademark: Delhi HC upholds trademark of Mebufen against Brufen Farhat Nasim26 Oct 2024 5:18 PM ISTNew Delhi: The Delhi High Court has upheld the Registrar of Trademarks' decision to reject an objection by pharmaceutical giant Abbott, which...
Abbott's review plea challenging NPPA ceiling price fixation of 18 formulations rejected by DoP Farhat Nasim16 Oct 2024 4:59 PM ISTNew Delhi: The Department of Pharmaceuticals (DoP) has dismissed two review applications filed by Abbott Healthcare Private Limited (AHPL) challenging...
Indian Pharma Market Grows 5.3% in September, Sun Pharma, Cipla take the lead: Pharmarack report Farhat Nasim14 Oct 2024 5:45 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) witnessed a growth of 5.3% in September 2024, primarily driven by the robust performance of key...
FDA Approves elimination of Aspirin use in HeartMate 3 LVAD Patients Dr. Kamal Kant Kohli23 Aug 2024 9:00 PM ISTThe US Food and Drug Administration has approved a labeling change that eliminates aspirin from the antithrombotic regimen alongside use with...
First trial against Abbott over premature infant formula commences in Missouri Ruchika Sharma11 July 2024 4:00 PM ISTIn a legal battle, the first trial against Abbott, the maker of Similac baby formula, commenced on Tuesday amidst allegations that its formula for...
Abbott gets USFDA clearance for 2 new OTC continuous Glucose monitoring system Ruchika Sharma11 Jun 2024 12:30 PM ISTAbbott Park, Ill.: Abbott has announced U.S. Food and Drug Administration (FDA) clearance for two new over-the-counter continuous glucose...
Aveir DR: Abbott gets CE mark for Dual chamber leadless pacemaker system Ruchika Sharma9 Jun 2024 10:00 AM ISTAbbott Park, Ill.: Abbott has announced the Company has received CE Mark in Europe for the AVEIR dual chamber (DR) leadless pacemaker system, a dual...
FDA approves dissolving stent for endovascular treatment of peripheral artery disease below knee Dr. Kamal Kant Kohli2 May 2024 8:45 AM ISTThe US Food and Drug Administration has approved Esprit BTK everolimus-eluting scaffold system for chronic limb-threatening ischemia (CLTI) below the...
